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Highlights: 
 TRP channels are heterogeneously expressed in glial cells. 
 Here we summarise the suggested roles for glial TRP channels in physiology and pathology. 
 More evidence is required to prove the existence and function of these glial TRP channels, 
and to determine how they contribute to pathology in stroke and other white matter diseases.   
 
Abstract 
Transient receptor potential (TRP) proteins are a large family of tetrameric non-selective cation 
channels that are widely expressed in the grey and white matter of the CNS, and are increasingly 
considered as potential therapeutic targets in brain disorders. Here we briefly review the evidence for 
TRP channel expression in glial cells and their possible role in both glial cell physiology and stroke. 
Despite their contribution to important functions, our understanding of the roles of TRP channels in 
glia is still in its infancy. The evidence reviewed here indicates that further investigation is needed to 
determine whether TRP channel inhibition can decrease damage or increase repair in stroke and other 
diseases affecting the white matter.  
Keywords: TRP channels; astrocytes; oligodendrocytes; microglia; ischaemia; pathogenesis 
 
Introduction  
The central nervous system is composed of grey and white matter. The grey matter contains the 
neurons while the main function of the white matter is to support fast and energetically-efficient 
transmission of neuronal signals over large distances in the brain. To accomplish this, the white matter 
contains myelin provided by oligodendrocytes, which decreases the effective capacitance of the 
axonal membrane, so that less charge entry is needed to generate an action potential, oligodendrocyte 
precursor cells (OPCs), astrocytes and microglia. The importance of white matter function is 
highlighted by the symptoms that develop when white matter tracts are damaged in stroke [1].  
It has long been realised that glial Ca2+ signalling is important for many glial cell functions 
including sensing and modulating the activity of local neurons (neuron-glial signalling; [2]), 
proliferation [3], migration [4] and myelination [5–7]. Furthermore, changes in local Na+ 
concentrations also have major physiological roles (reviewed by [8,9]). For these purposes the 
intracellular Na+ and Ca2+ concentrations are normally tightly regulated. When excessive increases 
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arise due to excitotoxicity, brain injury or stroke, this leads to pathological changes in cell 
functioning, mitochondrial damage, oxidative stress, the activation of proteolytic enzymes and 
eventually cell death by apoptosis or necrosis. In line with this, lowering the extracellular Ca2+ 
concentration during ischaemia protects against myelin damage [8] and loss of action potential 
propagation [9], and removing Na+ during ischaemia reduces damage to astrocytes [12]. Furthermore, 
astrocytes and microglia become “activated” when their intracellular Ca2+ concentrations increase 
during white matter damage [10,11].  
A wealth of evidence shows that ionotropic glutamate receptors mediate a large proportion of 
white matter damage by allowing a large flux of ions into glial cells, and this has been reviewed 
elsewhere in this issue. Here we focus on new evidence suggesting that glial cell TRP channels also 
regulate ion concentrations in glia, and that activation of these channels can damage glia and 
modulate glutamate excitotoxicity. During white matter pathology, the local environment changes in a 
way that would activate many TRP channels (for example by decreasing extracellular pH or 
increasing the production of free radicals). As activation of TRP channels on glial cells would result in 
a large cation flux, which in turn can indirectly activate voltage-operated calcium channels by 
depolarising the membrane, we propose that TRP channels are important causes of white matter 
damage in pathology which could be targeted for therapy. 
 
TRP channels in glial cells 
There are 28 mammalian TRP channels separated into 6 sub-families: TRPC (where C denotes 
canonical), TRPM (melastatin), TRPV (vanilloid), TRPA (ankyrin), TRPP (poly-cystin), and TRPML 
(mucolipin). They share some structural similarity, but their functions are diverse and they display an 
incredible variety of activation mechanisms. These include activation by a multitude of ligands, 
physical stimuli (e.g. force and temperature), differing local ion concentrations and secondary 
messengers released via G-protein coupled receptors.  There is a lot of evidence for the expression of 
TRPM, TRPV, TRPC and TRPA channels in glial cells, which we have reviewed here. However, the 
exact abundance and distribution of these TRP channels is still debated. While single cell mRNA 
analysis suggests that almost all TRP channels are expressed in subsets of glial cells [12], bulk 
sequencing studies that average the expression over large quantities of glia, have not found them. In 
the same manner, Shigetomi et al. [13], found that although Ca2+ imaging, anti-TRPA1 silencing RNA 
and pharmacology strongly suggested the presence of TRPA1 channels in astrocytes, they could not 
detect TRP protein by immunohistochemistry in the same cells. This discrepancy may exist because 
TRP channel expression is heterogeneous and not high enough to be measured as an average over 
many cells [12], and may also be because TRP channel expression is regulated by yet unknown 
factors which are changed between experiments, animals and disease models. Therefore, questions 
remain as to the degree, reason and timing of TRP channel expression, which we highlight below.  
TRPC channels  
The mammalian TRPC (canonical) family consists of seven members (TRPC1-7) that are 
organised into four groups depending on their sequence homology and functional similarities: TRPC1, 
TRPC2, TRPC3/6/7 and TRPC4/5 [14]. They are all non-specific cation channels with varying 
Ca2+:Na+ permeability ratios [15], that can be activated by diacylglycerol (DAG), and thus Gq-
coupled receptors generating DAG such as group 1 mGluR and muscarinic acetylcholine receptors, 
and possibly by mechanical stimulation [16]. In line with this, astrocyte TRPC1 is activated by 
glutamatergic or purinergic metabotropic receptors, or mechanical stimulation [17,18]. TRPC 
channels form heteromeric complexes that alter their biophysical properties and agonist profiles [19] 
making them difficult to identify pharmacologically. Despite this, TRPC1, 2, 3, 4 and 6 have been 
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found to be expressed by astrocytes [17,20–23], and TRPC3 [24] and TRPC6 [25] by microglia 
(reviewed by [26]). TRPC channels have also been found in the oligodendrocyte lineage, where 
TRPC1-6 are more highly expressed by OPCs and newly forming oligodendrocytes, and TRPC7 has 
greater expression in some mature oligodendrocyte populations [12]. Unlike astrocytes, the function 
of most TRPCs in oligodendrocyte lineage cells has not been explored to date. 
TRPC1 
Soon after the discovery of TRPC1 it was proposed to underlie store-operated Ca2+ entry (SOCE; 
Boulay et al., 1999). Stromal interaction molecule (STIM1 and STIM2) and Orai (1, 2 and 3) have 
since been held mainly responsible for this process, however convincing evidence still exists for a 
TRPC1-mediated component [28,29], and in oligodendrocyte precursor cells, small interfering RNA 
knockdown of TRPC1 reduces SOCE [30]. As TRPC1 forms heteromers with TRPC3, TRPC4 and 
TRPC5, it has also been postulated that a multimer may be responsible for astrocyte SOCE [31]. In 
line with this, TRPC3 inhibitors reduce SOCE in spinal astrocytes [23]. However in another study, 
knockout of TRPC1 or TRPC3 and TRPC6 did not affect SOCE in cortical astrocytes [20], and TRPC 
appears to have no role in SOCE in primary microglia [32]. Thus, the mechanisms responsible for 
SOCE in glial cells may be more complicated than supposed, and may differ between cell types [28].  
Along with mediating SOCE in astrocytes, TRPC1 has the potential to regulate a huge variety of 
functions and to damage cells if they are excessively activated. Thus, astrocytes with TRPC1 
genetically removed display increased migration in vitro and have increased injury-evoked 
astrogliosis in vivo [20]. Blocking TRPC1 with antibodies reduces glutamate release from cultured 
astrocytes [17]. This TRPC1-mediated control of glutamate release may regulate astrocyte-mediated 
effects on neuronal function during normal physiology [2], or influence ischaemia-evoked glutamate 
excitotoxicity in stroke.  
TRPC2 
 TRPC2 is a pseudogene in humans but in rodents regulates the activity of the vomeronasal organ 
and the testis. In wildtype mice, only male mice mount other mice, usually a female. However in 
Trpc2 -/- mice, both males and females mount other mice indiscriminately (reviewed by [33]). Only 
very low levels of TRPC2 have been found in astrocytes [20,22], microglia [32] and OPCs [12].  
TRPC3 
Like TRPC1, TRPC3 is activated by store depletion [28] and forms heteromeric channels with 
TRPC1 [20] and TRPC7 [34]. In contrast to TRPC1, TRPC3 dependent Ca2+ signalling in mouse 
cortical astrocytes increases proliferation and migration, and increases inflammation and oedema in 
stab wound injuries [20], and astrogliosis after ischaemia  [35]. In line with that, TRPC3/C6/C7 
knockouts are protected against ischaemia-evoked astrocyte apoptosis and have a reduced ischaemia-
evoked infarct size [21], and ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-
pyrazole-4-carboxylate (Pyr3), a TRPC3 antagonist, decreases astrogliosis in an in vivo intracerebral 
haemorrhage model [36]. Interestingly, immunolabelling for TRPC3 showed its expression mainly in 
oligodendrocytes [37], and therefore it may play a part in myelination as well as white matter 
pathology. Together, these data suggest that therapies targeted at TRPC3 may successfully inhibit 
white matter damage.  
TRPC4 and TRPC5 
 Based on structural similarities, TRPC4 and TRPC5 are most closely related to TRPC1. These 
structural similarities aid in the formation of heterotetramers, and therefore tetramers involving 
TRPC1, TRPC4 and TRPC5 are common. This group of TRPC channels is activated following 
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stimulation by GPCRs of the Gq/11 family which couple to PLCβ, or receptor tyrosine kinases which 
couple to PLCγ [38]. Thus activation of the channels can be inhibited by inhibition of PLC [39]. Some 
variability in activation mechanism between different species is found, and has been extensively 
reviewed here [38].  
TRPC4 and TRPC5 are expressed in astrocytes [17,40,41], with TRPC4 at discrete cell to cell 
contact sites [41]. There, TRPC4 with TRPC1 have been suggested to raise intracellular Ca2+ by 
mediating SOCE [40,41]. TRPC4 expression also increases in neurons in an in vivo model of 
ischaemia [42], however whether TRPC4 acts in a positive or detrimental manner is uncertain. The 
role of TRPC5 is unknown. 
 
TRPC6 
Immunoblotting, siRNA, knockout and Ca2+ imaging experiments suggest that TRPC6 is 
expressed in astrocytes [21,43,44] and microglia [25]. TRPC6 mRNA is also expressed in freshly 
dissociated oligodendrocyte lineage cells, but at a decreasing level as the cells mature [12]. A role for 
TRPC6 in inflammation and astrogliosis is supported by evidence that knockout of TRPC3/6/7, 
protects astrocytes against apoptosis during ischaemia in vitro and decreases the ischaemia-evoked 
infarct size in vivo [21]. As these channels are also involved in regulating vascular tone [45], this 
protection may also be due to changes in local perfusion. The relative contribution of the different 
TRPCs are unknown, and how their knockout affects other cell types has not been determined.  
 
TRPC7 
TRPC7 appears to be expressed in the human and rodent brain, but not in cultured astrocytes [44], 
or in optic nerve head astrocytes [22].  In contrast, transcriptome data from astrocytes in the whole 
brain suggest that TRPC7 may be expressed to some extent [46], and single cell transcriptome data 
from oligodendrocyte lineage cells suggest that TRPC7 is expressed by some myelinating and mature 
oligodendrocyte populations [12]. The functions of glial cell TRPC7 are unknown. 
 
TRPM channels 
The mammalian TRPM (melastatin) family consists of eight channels, TRPM1-TRPM8, that can 
be divided into four groups based on their sequence homology: TRPM1/3, TRM2/8, TRPM4/5 and 
TRPM6/7. They mediate a cation flux, but have a variable degree of Ca2+ permeability: TRPM4 and 
TRPM5 are Ca2+-impermeable, TRPM3, TRPM6 and TRPM7 are highly permeable to both Ca2+ and 
Mg2+, and the rest fit somewhere in between [15]. Like TRPC channels, almost all of the TRPM 
family (except TRPM8) have been determined to be expressed heterogeneously within different 
populations of glial cells [12,47–51]. However, our understanding of the functional role of TRPM 
channels in glial cells is limited.  
TRPM1  
TRPM1 is interesting as it is constitutively active and allows Ca2+ to enter cells that are still 
hyperpolarised. Its activity is inhibited by the activation of G-proteins, and mutations in TRPM1 can 
cause congenital night blindness [52]. Single cell transcriptome data suggest that TRPM1 can be 
expressed by oligodendrocyte lineage cells throughout their development [12], however the activation 
mechanism(s) and the function of TRPM1 in glial cells has not been explored.  
TRPM2  
TRPM2 is a chanzyme, made up of a channel fused with an enzymatic ADP-ribose 
pyrophosphatase domain, which is activated by ADP-ribose, NAD+, Ca2+ and heat. TRPM2 is 
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expressed by both astrocytes [46,50] and microglia [46], where it is thought to have a role in 
regulating immune cell function [53,54] and gliosis [49,55]. Importantly, TRPM2 knockout reduces 
ischaemia-evoked brain damage and activation of both astrocytes and microglia [55]. Its is not known 
whether this in vivo effect is increased by TRPM2 knockout from local neurons, which may indirectly 
activate glial cells. TRPM2 can be activated by reactive oxygen species and inflammatory cytokines, 
as well as ADP-ribose, and therefore is more likely to be activated during the reperfusion phase of 
ischaemia-reperfusion insults [55], when these substances are produced. Single cell transcriptome 
analysis suggests that this channel is more likely to be expressed in the oligodendrocyte lineage after 
differentiation [12], however transcriptome analysis of larger populations of glial cells suggest 
TRPM2 is expressed mainly by OPC populations [46], indicating that TRPM2 may be expressed in 
more OPCs at lower levels, and then increases its expression in only a proportion of the cells as they 
mature. Their function in oligodendrocyte lineage cells is unknown. 
TRPM3 
TRPM3 may have an important role in regulating glial cell Ca2+ concentrations, as it has been 
detected at relatively highly levels in astrocytes [46,51] and mature (or myelinating) oligodendrocytes 
[12,47,51], and can regulate SOCE in these cells in the rodent optic nerve [51]. TRPM3 has many 
splice variants, which may modulate its pharmacological profile [56,57] and these variants can be 
differentially expressed in the oligodendrocyte lineage [47]. TRPM3 is activated by D-erythro-
sphingosine, pregnenolone sulphate and a decrease in extracellular osmolarity. As sphingosine is a 
major constituent of myelin, and TRPM3 is most greatly expressed around the time that myelination 
and myelin compaction occurs [47], TRPM3 may regulate the formation of the myelin sheath. 
TRPM3 also modulates glutamate release and mEPSC frequency in neonatal Purkinje cells [58]. 
Whether this mechanism is activated in glial cells or ischaemia, or whether it affects glial cells 
indirectly is unknown.   
TRPM4/5 
Though impermeable to Ca2+, TRPM4 and TRPM5 are activated by intracellular Ca2+ and are 
therefore thought to play some role in controlling Ca2+ concentrations. Recent evidence also suggests 
that astrocytes express a sulfonylurea receptor 1 (SUR1)-TRPM4 and aquaporin-4 (AQP4) complex 
that regulates water movement and astrocyte swelling after injury [59]. TRPM4 is considered to form 
the pore of the SUR1/TRPM4 channel and SUR1 is a subunit of KATP channels. SUR1 is not believed 
to normally be expressed by glial cells, but is upregulated in astrocytes and microglia during stroke 
[60]. Whether TRPM4 ever forms this complex in oligodendrocytes is unknown, although TRPM4 
RNA has been detected in subpopulations of oligodendrocytes and OPCs. There is no evidence for 
TRPM5 expression in glial cells.  
TRPM6/7 
Unlike other TRP channels, TRPM6 and TRPM7 have functional -kinases that have structural 
similarity to protein kinase A [61] that are covalently linked to the C-termini. Both channels are 
constitutively active Mg2+-permeable channels that are negatively regulated by intracellular Mg2+, 
thus regulating [Mg2+]i in the cells that express them [62]. There is only evidence for expression of 
TRPM7 in glial cells, which is thought to play roles in controlling migration and proliferation of 
astrocytes [46,63] and microglial migration and invasion [64]. TRPM7 is also found in OPCs [12], 
newly formed oligodendrocytes and endothelial cells [46]. Its function in these cells is unknown, but 
as it contributes extensively to pH-dependent neuronal damage during ischaemia, through Ca2+ 
overload, and generation of ROS [65,66], TRPM7 may also damage glial cells in the same situation.  
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TRPM8 
TRPM8 has received a lot of interest, because it can be activated by low temperatures as well as 
menthol, eucalyptol and icilin [67]. It is expressed in primary afferent sensory neurons, but not 
thought to be expressed in the brain or by glial cells. 
 
TRPV channels 
There are six mammalian vanillin TRP channels that fit into four groups, TRPV1/2, TRPV3, 
TRPV4 and TRPV5/6 based on their sequence homology. All groups are Ca2+ selective however 
TRPV5/6 are the most highly Ca2+ selective channels in the TRP family [19]. They all can form 
homotetramers or heterotetramers.  
TRPV1 
 TRPV1 is most highly expressed in peripheral sensory neurons, where extensive studies have 
found that it responds to physical and chemical stimuli such as noxious heat (>43°C), acidity, ROS, 
capsaicin and endogenous compounds such as arachidonic acid metabolites and endocannabinoids 
[19]. It is also expressed in the brain in neurons, astrocytes and microglia (for a review see [68]).  
 Due to the high Ca2+ permeability of TRPVs, and the ability of TRPV1 to be activated in 
hypoxia and inflammation, researchers have investigated its contribution to pathology. Interestingly, 
TRPV1 activation in glial cells is not always detrimental. On one side, TRPV1 expression in 
microglia has been suggested to disrupt mitochondria [69], increase ROS production [70,71] and 
mediate neuropathic pain [72]. Conversely, TRPV1 activation helps promote microglial-phagocytosis 
of damaged cells [73] and reduces microglia-induced oxidative stress [74,75].  
TRPV1 has been shown to be expressed in astrocyte end feet [76] or thick processes [77], and to 
influence the migration of astrocytes when they become reactive [78]. However surprisingly, no 
change in the reaction of astrocytes or microglia was observed in after middle cerebral artery 
occlusion when TRPV1 was genetically removed or inhibited, despite there being a decrease in infarct 
volume and neurological deficits [79]. 
Whether TRPV1 is also activated in oligodendrocyte lineage cells is unknown, but this appears not 
to be the case for mature oligodendrocytes in the rat cerebellum, which do not respond when the 
TRPV1 agonist capsaicin is applied [80]. However, TRPV1 RNA is found in subpopulations of 
oligodendrocyte lineage cells [12] and TRPV1 immunolabelling is in alvear oligodendrocytes of the 
hippocampus [81]. Although there are many studies on the actions of TRPV1 in the brain, it not 
thought to be widely expressed there. More investigation will confirm whether it really is involved in 
these diverse functions.  
 
TRPV2 
TRPV2 can be activated by very high temperatures (>52°C), mechanical force, osmotic pressure 
and lipids [82]. Whether it is expressed by astrocytes is unclear, as it was not found in cultured human 
astrocytes [83] or rat retinal Muller cells or astrocytes [84], but was found in mouse cerebellar [85] 
and cortical [86] astrocytes. TRPV2 expression by cortical astrocytes in mice is thought to be 
enhanced during ischaemia, and blocking TRPV2 increases nerve growth factor-induced 
neuroprotection [86]. TRPV2 in microglia, like TRPV1, is thought to increase microglial 
phagocytosis evoked by cannabidiol (by 175%) [73]. It is also found at low levels in newly forming 
oligodendrocytes [12]. More work is needed to confirm the true extent of TRPV2 expression and its 
function.  
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TRPV3 
TRPV3 is a rather underexplored TRP channel, activated by a variety of natural compounds such 
as carvacrol (which gives the smell of oregano), thymol, and eugenol [87]. It senses innocuous warm 
temperatures (22-40°C; [88,89]), and is inhibited by metabolites of omega 3 fatty acids, 
eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) [90]. It is widely expressed in the 
human body, mainly in keratinocytes and the brain. However, the role of TRPV3 in the brain is not 
known. We have no evidence suggesting that TRPV3 is expressed by either astrocytes or microglia, 
however in situ hybridisation of rodent cerebellum shows that TRPV3 is expressed in mature 
oligodendrocytes in the rat, but not in the mouse [80]. Although a TRP channel with properties similar 
to TRPV3 contributes to the Ca2+ influx occurring into rat cerebellar oligodendrocytes during 
ischaemia, a TRPV3 component could not be confirmed due to a lack of specific TRPV3 antagonists, 
and because only TRPV3 knockout mice and not rats are available [80].  
 
TRPV4 
TRPV4 has a role in regulating vascular function and the osmotic pressure in the brain [91]. It is 
highly expressed throughout the brain in glial cells [92–98], and TRPV4 mutations lead to 
neurological motor function disorders such as congenital distal spinal muscular atrophy, and a subtype 
of Charcot-Marie-Tooth disease [99]. Its activation is regulated by cell swelling and low extracellular 
pH. Therefore, TRPV4 may play an important role in glial cell pathophysiology associated with 
neurodegenerative diseases and ischaemia.  
 TRPV4 is expressed in the membrane of astrocytes, mainly on their processes, and its 
expression increases when they become reactive after ischaemia [93,97]. Astrocyte TRPV4 activation 
results in extracellular glutamate accumulation, which may contribute to glutamate excitotoxicity 
during ischaemia [97] or modulate synaptic function [100].  
These results indicate that TRPV4 may be a useful therapeutic target in ischaemia, however 
TRPV4 antagonists may have an unwanted effect on neurovascular coupling. TRPV4-mediated Ca2+ 
signals in astrocyte end feet are activated by local neuronal activity, regulate astrocyte cell volume, 
and enhance the induced vasodilation [94]. These responses are augmented and propagated by Ca2+-
induced Ca2+ release  [94].   
 TRPV4 also increases OPC proliferation with no effect on OPC differentiation [96], 
suggesting that TRPV4 activation may be a useful therapy for increasing OPC numbers in culture for 
cell transplantation, or briefly in vivo, after a bout of demyelination. These results are promising and 
highlight the fact that the role of TRPV4 in glial cells in the brain is under researched.  
 
TRPV5/TRPV6 
TRPV5 and TRPV6 are the most highly Ca2+-selective TRP channels and are also interesting 
because of their possible link with neuroendocrine regulation. TRPV5 is primarily expressed in 
kidney epithelial cells, however it is also expressed at lower levels in the brain. Immunolabelling for 
TRPV5 indicates it is expressed in neurons and astrocytes [101]. In the arcuate nucleus, TRPV5 
expression in astrocytes seems to be regulated by 17-oestradiol or ischaemia, where it can cause a 
detrimental Ca2+ concentration rise [101].  
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TRPA1 channels 
TRPA1 is the only member of the ankyrin family of TRP channels, so named because of the 
extensive number of ankyrin repeats located on its intracellular N-terminus [102]. It is best known as 
a sensor for environmental irritants and endogenous electrophilic compounds that are formed during 
oxidative stress [103] and evoke pain, cold, itch and inflammation [104], however it probably also has 
other undiscovered functions. In support of this assumption, along with decreased responses to 
peripheral pain models and temperature changes, global TRPA1 knockouts are hyperactive [105], and 
have sensory dysregulation, cognitive dysfunction, and motor deficits proposed to result from a 
decrease in myelination [106].  
The role of TRPA1 and its expression in rodent glial cells is still contentious, as TRPA1 
expression appears to be low [13,46], or only in scattered cells [12]. TRPA1 RNA was also not found 
in the optic nerve during studies of SOCE in glial cells [51]. However, using in situ hybridisation, we 
found low levels of TRPA1 RNA in most oligodendrocyte lineage cells [80]. Remarkably, TRPA1 
knockout is also protective in the cuprizone model of demyelination [107].  
In astrocytes, TRPA1 is thought to elevate the resting astrocyte Ca2+ concentration, which in turn 
modulates inhibitory synapse efficacy by controlling the membrane insertion of astrocyte GABA 
transporters (GAT-3) [13]. TRPA1-mediated Ca2+ signals are in discrete zones in the astrocyte 
processes [13], which can also be activated by amyloid- oligomers [108], suggesting a possible role 
for astrocyte TRPA1 in the dysregulation of synaptic activity in Alzheimer’s pathology.  
As well as its role in inhibiting transporters, TRPA1 activation in cultured astrocytes can evoke the 
release of peptide hormones [109] and regulate long-term potentiation in the hippocampus via release 
of D-serine [110]. However, as in oligodendrocytes [80], TRPA1 expression in astrocytes appears to 
be too low to be observed with immunohistochemistry [13]. Although strong immunolabelling of 
TRPA1 in astrocytes and reactive astrocytes has been shown [107], this TRPA1 antibody strongly 
colocalises with GFAP even in TRPA1 knockouts (our unpublished observations). Therefore, the 
protective effect of TRPA1 knockout in the cuprizone model [107,111] may reflect protection from 
TRPA1 expression in either astrocytes or oligodendrocytes, or both. 
Importantly, like some other TRP channels, TRPA1 expression is upregulated during inflammation 
[104,112,113], and therefore it may be important to measure TRPA1 expression in single cells during 
disease, to determine whether it plays a greater role than predicted by sequencing data from cells in 
healthy animals. Nonetheless, the evidence indicates that TRPA1 plays a role in glial cell regulation 
and homeostasis in the CNS, and that TRPA1 inhibition may be therapeutic in neurodegenerative 
diseases affecting the white matter.  
Summary 
The evidence reviewed here identifies many TRP channels that might regulate important glial cell 
functions and contribute to pathological signalling (Figure 1). Heterogeneity of receptor expression in 
glial cells exists within the same brain regions and this may explain why controversy exists in the 
literature over how white matter becomes damaged in disease. Although it is apparent that 
glutamatergic and purinergic receptors play a large role in causing white matter damage in ischaemia, 
the work reviewed here shows that the role of TRP channels in glial cell function and pathology is 
heavily underexplored, and that a combinatorial approach to treatment during white matter 
pathologies may be beneficial. 
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Figure 1 
A schematic to illustrate the evidence for TRP channel expression in glial cells.  
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